// App-Quantinova.ai

: Clinical and genomic characterization of low-prostate-specific antigen, high-grade prostate cancer.

Researchers

Presenter

  • Brandon Arvin Virgil Mahal

Principal Investigators

  • David Dewei Yang

  • Natalie Wang

  • Mohammed Alshalalfa

  • Elai Davicioni

  • Voleak Choeurng

  • Daniel Eidelberg Spratt

  • Neil E. Martin

  • Kent William Mouw

  • Peter F Orio

  • Toni K. Choueiri

  • Quoc-Dien Trinh

  • Felix Y Feng

  • Paul L. Nguyen

Medical Centers

  • Brigham and Women's Hospital, Brookline, MA

  • Harvard Medical School, Boston, MA

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Dana-Farber Cancer Center/Brigham and Women's Hospital, Boston, MA

  • Dana-Farber Cancer Institute, Boston, MA

  • Dana-Farber Cancer Institute, Boston, MA

  • Dana-Farber-Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA

  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  • University of California, San Francisco, San Francisco, CA

  • Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, MA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved